PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN MICE FOLLOWING ADMINISTRATION OF ALLOTRAP1
EFFECTS OF RS61443 ON FUNCTIONAL AND MORPHOLOGICAL CHANGES IN CHRONICALLY REJECTING RAT KIDNEY ALLOGRAFTS1,2
RETRANSPLANTATION AFTER RENAL ALLOGRAFT LOSS DUE TO NONCOMPLIANCE1,2
LACK OF EFFECT OF PREGNANCY ON RENAL ALLOGRAFT SURVIVAL OR FUNCTION1
VARIABLES AFFECTING BIRTHWEIGHT AND GRAFT SURVIVAL IN 197 PREGNANCIES IN CYCLOSPORINE-TREATED FEMALE KIDNEY TRANSPLANT RECIPIENTS1,2
PRIMARY KIDNEY TUMORS BEFORE AND AFTER RENAL TRANSPLANTATION1,2
A PROSPECTIVE RANDOMIZED TRIAL OF FK506-BASED IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION1
THROMBOXANE SYNTHASE EXPRESSION IN RENAL TRANSPLANT PATIENTS WITH REJECTION1
URINE CYTOLOGY AND URINE FLOW CYTOMETRY IN RENAL TRANSPLANTATION—A PROSPECTIVE DOUBLE BLIND STUDY1
ANALYSIS OF REJECTION OUTCOMES AND IMPLICATIONS—A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY1
REDUCED INTER- AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A MICROEMULSION FORMULATION IN CONJUNCTION WITH FASTING, LOW-FAT MEALS, OR HIGH-FAT MEALS1,2
SEQUENTIAL PROTOCOL BIOPSIES IN RENAL TRANSPLANT PATIENTS
QUALITY OF LIFE IMPROVEMENTS AT ONE, TWO, AND FIVE YEARS AFTER LIVER TRANSPLANTATION1,2
VIRAL AND IMMUNOLOGIC ASPECTS OF EPSTEIN-BARR VIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS1
AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION1
FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER TRANSPLANTATION
AN IMPROVED GLOMERULAR FILTRATION RATE IN CARDIAC TRANSPLANT RECIPIENTS WITH ONCE-A-DAY CYCLOSPORINE DOSING1,2
BONE PAIN THAT RESPONDS TO CALCIUM CHANNEL BLOCKERS
IN VITRO PROPAGATION AND HOMING OF LIVER-DERIVED DENDRITIC CELL PROGENITORS TO LYMPHOID TISSUES OF ALLOGENEIC RECIPIENTS
SOLUBLE CTLA4Ig MODIFIES PARAMETERS OF ACUTE INFLAMMATION IN RAT LUNG ALLOGRAFT REJECTION WITHOUT ALTERING LYMPHOCYTIC INFILTRATION OR TRANSCRIPTION OF KEY CYTOKINES1
INCREASED EXPRESSION OF IL-4 AND IL-10 AND DECREASED EXPRESSION OF IL-2 AND INTERFERON-γ IN LONG-SURVIVING MOUSE HEART ALLOGRAFTS AFTER BRIEF CD4-MONOCLONAL ANTIBODY THERAPY1,2
ISCHEMIC ACUTE TUBULAR NECROSIS INDUCES AN EXTENSIVE LOCAL CYTOKINE RESPONSE
UPREGULATION OF CYTOKINES ASSOCIATED WITH MACROPHAGE ACTIVATION IN THE LEWIS-TO-F344 RAT TRANSPLANTATION MODEL OF CHRONIC CARDIAC REJECTION1,2
LOW FREQUENCY OF INFILTRATING CELLS INTENSELY EXPRESSING T CELL CYTOKINE mRNA IN HUMAN RENAL ALLOGRAFT REJECTION1,2
DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR ADHESION MOLECULE-1 (cICAM-1) AND VASCULAR CELL ADHESION MOLECULE-1 (cVCAM-1) DURING LIVER ALLOGRAFT REJECTION1,2
THE ALLOANTIBODY NETWORK FOLLOWING INTRATHYMIC IMMUNOMODULATION OF SENSITIZED RAT RECIPIENTS OF CARDIAC ALLOGRAFTS1,2
HEAT SHOCK PROTEIN REACTIVITY OF LYMPHOCYTES ISOLATED FROM HETEROTOPIC RAT CARDIAC ALLOGRAFTS1,2
CONFIRMATION OF ALTERNATIVELY SPLICED PLATELET-DERIVED GROWTH FACTOR-A CHAIN AND CORRELATION WITH EXPRESSION OF PDGF RECEPTOR-α IN HUMAN CARDIAC ALLOGRAFTS1,2
THE INDIRECT PATHWAY OF ALLORECOGNITION
IMMUNE STATUS OF RECIPIENTS FOLLOWING BONE MARROW-AUGMENTED SOLID ORGAN TRANSPLANTATION1,2
APOPTOSIS AS A MECHANISM OF CELL DEATH IN LIVER ALLOGRAFT REJECTION1,2
A RAPID FLOW CYTOMETRY ASSAY FOR HLA ANTIBODY DETECTION USING A POOLED CELL PANEL COVERING 14 SEROLOGICAL CROSSREACTING GROUPS1
OBESITY AS A RISK FACTOR FOLLOWING RENAL TRANSPLANTATION1
AUTONOMIC CARDIAC DYSFUNCTION IN DIABETIC TRANSPLANT RECIPIENTS SUCCUMBING TO SUDDEN CARDIAC DEATH1,2
POSTTRANSPLANT EPSTEIN-BARR VIRUS INFECTION IS ASSOCIATED WITH ELEVATED LEVELS OF CD19+ B LYMPHOCYTES1
THE INFLUENCE OF HLA DONOR-RECIPIENT COMPATIBILITY ON THE RECURRENCE OF HBV AND HCV HEPATITIS AFTER LIVER TRANSPLANTATION1
THE USE OF SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF LIVING DONORS FOR KIDNEY TRANSPLANTATION1
THE FATE OF THE FAILED RENAL TRANSPLANT1